The Physicians Committee for Responsible Medicine filed a complaint today, May 21, 2025, with the National Institutes of Health’s Office of Laboratory Animal Welfare requesting an investigation of Texas Tech University Health Sciences Center’s study of the effects of ginger root extract on pain in rats. The group also sent a letter to Texas Tech University President Lori Rice- Spearman on April 14, 2025, requesting the shuttering of any additional animal experiments currently underway by the same researchers.

This study identified a promising trend of declining sedentary behavior among U.S. adults between 2013 and March 2020, but this decline was hampered in 2021-2023. Sedentary lifestyle was widely exacerbated during the COVID-19 pandemic, and this study highlights the enduring impact that this global pandemic may have on daily living patterns. 

A potent combination of antimalarial compounds added to bed nets blocked parasite transmission in mosquitoes while circumventing insecticide resistance, according to a new study led by researchers at Harvard T.H. Chan School of Public Health. The finding dramatically expands understanding of druggable targets in mosquito-stage parasite development and lays the groundwork for a new, more effective way to prevent malaria transmission.

Analysis of newly launched children’s ready-to-eat cereals from 2010 to 2023 revealed concerning nutritional shifts: notable increases in fat, sodium, and sugar alongside decreases in protein and fiber. Children’s cereals contain high levels of added sugar, with a single serving exceeding 45% of the American Heart Association’s daily recommended limit for children. These trends suggest a potential prioritization of taste over nutritional quality in product development, contributing to childhood obesity and long-term cardiovascular health risks.

Research teams funded by the National Institutes of Health (NIH) have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy. These delivery systems are a significant step toward future precise gene therapy to the brain that could safely control errant brain activity with high precision. In contrast, current therapies for brain disorders mostly treat only symptoms.